US EditionMEGGLE’s MicroceLac® Plus - A new benchmark in tabletability by outperforming conventional DC excipients - Pharma Excipients
Summary by Pharma Excipients
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
MEGGLE’s MicroceLac® Plus - A new benchmark in tabletability by outperforming conventional DC excipients - Pharma Excipients
MicroceLac® Plus The new co-processed Excipient for Direct Compression (DC) What’s new? What’s special? MicroceLac® Plus is an innovative addition to the MEGGLE co-processed excipients line, combining 35% alpha-lactose monohydrate and 65% microcrystalline cellulose (MCC) to enhance tablet formulations. This CPE offers a remarkable set of advantages, most notably its superior tabletability! It achieves tablet hardness that exceeds not only its in…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
